Published 6:00 pm Friday, October 30, 2026 When Tricia Ducote Wilson was diagnosed with stage 3 Metastatic Invasive Ductal Carcinoma in 2021, she began a journey that would test her strength, reshape her understanding of health and deepen her determination to help other women recognize…
Tetley Tea's A Life-Changing Cuppa campaign, builds on a ritual embedded in Australian life. This is branded content for Tetley Tea. With 56 Australians diagnosed with breast cancer every day, Breast Cancer Network Australia and Tetley Tea are encouraging people to…
For 18 Rush surgeons, students and staff members, the Chicago Marathon was more than a race. It was an opportunity to support the Rush programs and services they care about most while helping advance Rush’s mission. Together, Team Rush raised $41,373 ahead…
Lunit will present two studies showing how AI-powered pathology can identify tissue features associated with homologous recombination deficiency (HRD) in ovarian cancer and immune patterns linked to immunotherapy response in bladder cancer at the Society for Immunotherapy of Cancer (SITC)…
From December 1, 2026, individuals who are at risk of hereditary breast and ovarian cancer (HBOC) will be able to undergo genetic testing at three public healthcare clusters. This was announced by the Ministry of Health (MOH) in a news release on…
A Medicine Plus review examines artificial intelligence (AI) and radiomics across osteosarcoma imaging, from diagnostic support and tumor segmentation to treatment response and risk assessment. It highlights the need for disease-specific evidence, external validation, and clinically meaningful evaluation before routine…
The seventh annual She Shines Women’s Empowerment Conference, scheduled for Saturday, Nov. 7, at New Covenant Church of Philadelphia, 7500 Germantown Ave. in West Mt. Airy, will focus on health, healing, wellness, spirituality, education, safety, civic engagement, networking opportunities, and offer a…
PIKEVILLE, Ky. — Lawson Cancer Center at Pikeville Medical Center has launched a lymphedema prevention program that uses a noninvasive device to help identify fluid changes before patients notice swelling. The program uses the SOZO Digital Health Platform, which measures fluid…
EurekAlert! Fig. 1. Schematic of the “dual-boosting” strategy for developing mitochondria-targeted type-I PSs. Credit: Copyright © 2026 Limin Wang et al. McL3 was subsequently self-assembled with human serum albumin (HSA) to form McL3@HSA nanoparticles with an average size of approximately 40 nm. Benefiting from the…
As low-cost and straightforward an intervention as automated text messaging could make a significant contribution to tackling London's below-average bowel cancer screening rates, according to a major study led by the University of Surrey. The project compared two approaches to…
Screening, genetics, surgical/medical treatment, and survivorship supports.
An article joins this feed when it matches these terms. Each one is also a search of its own.